OURVITA to unveil new nutra concepts spanning hydration, longevity, and gut health at Vitafoods Europe 2026
Published: 15 May 2026
Author: Towards Healthcare
Ourvita is the largest Europe-based food supplements CDMO, with a global footprint. It is committed teams all built around a customer-centric approach. Our story is one of dedicated people coming together with their own expertise, resilience, service quality, and consumer insight to create something unique, new, and powerful.
The company's vision is for high-quality health and medical products to be available when and where people need them, transforming lives and advancing healthcare worldwide through our commitment to development, distribution, and building a network of global partners.
According to Towards Healthcare, the vitamins, minerals, and supplements CDMO market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 52.84 billion in 2026 to approximately USD 121.38 billion by 2035, representing a compound annual growth rate (CAGR) of 9.68% from 2026 to 2035. Growth is driven by the increasing consumer preference for personalized nutrition. This trend is particularly pronounced among millennials and Gen Z, prompting brands to seek CDMO partners that can offer innovative formulation capabilities and flexible manufacturing options.
CEO Matthias Brommer said, participating in Vitafoods is always a pivotal moment for us. It's not just about showcasing our latest innovations, but about engaging directly with partners, customers, and industry leaders to understand where the market is heading.
About Ourvita
Ourvita is a contract development and manufacturing organization (CDMO) that specializes in the health and wellness sector. The company develops and manufactures a variety of products, including food supplements, medical devices, cosmetics, and probiotics.
It focuses on innovation, quality, and customer-centricity. The company supports partners across the full product lifecycle - from idea generation to commercialisation - bringing cutting-edge health solutions to market.
Our vision is for high-quality health and medical products to be available when and where people need them, transforming lives and advancing healthcare worldwide through our commitment to development, distribution, and building a network of global partners. 15 manufacturing sites in Italy, Germany, Poland, the UK, the USA, and China
A recent report by Towards Healthcare highlights that the vitamins, minerals, and supplements CDMO market is witnessing growth due to the increasing demand for consumer focus on preventative health, the rise of personalized nutrition, the demand for innovative formulations, the trend of outsourcing manufacturing to specialized CDMOs, technological advancements, and the need for compliance with complex regulatory requirements.